Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 8 July 1977:
Vol. 197. no. 4299, pp. 165 - 167
DOI: 10.1126/science.877547
Prev | Table of Contents | Next

Articles

Science, Vol 197, Issue 4299, 165-167
Copyright © 1977 by American Association for the Advancement of Science

articles

Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response

CE Myers, WP McGuire, RH Liss, I Ifrim, K Grotzinger, and RC Young

The antitumor antibiotic, adriamycin, induces severe cardiac toxicity associated with peroxidation of cardiac lipids in mice. Both this lipid peroxidation and cardiac toxicity of adriamycin are reduced by prior treatment of the animals with the free radical scavenger tocopherol. Such treatment with tocopherol does not, however, alter the magnitude or duration of the adriamycin-induced suppression of DNA synthesis in P388 ascites tumor, nor does it diminish the antitumor responsiveness of P388 ascites tumor. These results suggest that adriamycin has at least two mechanisms of tissue damage: one, which involves lipid peroxidation, is blocked by tocopherol and results in cardiac toxicity; the other, which involves binding to DNA, is not antagonized by tocopherol and is responsible for tumor response.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Oral Glutamine Protects against Acute Doxorubicin-Induced Cardiotoxicity of Tumor-Bearing Rats.
V. K. Todorova, Y. Kaufmann, L. Hennings, and V. S. Klimberg (2010)
J. Nutr. 140, 44-48
   Abstract »    Full Text »    PDF »
CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes.
P. Mukhopadhyay, M. Rajesh, S. Batkai, V. Patel, Y. Kashiwaya, L. Liaudet, O. V. Evgenov, K. Mackie, G. Hasko, and P. Pacher (2009)
Cardiovasc Res
   Abstract »    Full Text »    PDF »
Drug-related cardiac pathology.
J Butany, E Ahn, and A Luk (2009)
J. Clin. Pathol. 62, 1074-1084
   Abstract »    Full Text »    PDF »
Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins.
Y. Bian, M. Sun, M. Silver, K. K. L. Ho, M. A. Marchionni, A. O. Caggiano, J. R. Stone, I. Amende, T. G. Hampton, J. P. Morgan, et al. (2009)
Am J Physiol Heart Circ Physiol 297, H1974-H1983
   Abstract »    Full Text »    PDF »
Deletion of the NADPH-Cytochrome P450 Reductase Gene in Cardiomyocytes Does Not Protect Mice against Doxorubicin-Mediated Acute Cardiac Toxicity.
C. Fang, J. Gu, F. Xie, M. Behr, W. Yang, E. D. Abel, and X. Ding (2008)
Drug Metab. Dispos. 36, 1722-1728
   Abstract »    Full Text »    PDF »
Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1.
R. Gao, D. K. Price, T. Sissung, E. Reed, and W. D. Figg (2008)
Mol. Cancer Ther. 7, 1246-1250
   Abstract »    Full Text »    PDF »
Erythropoietin Pretreatment Protects Against Acute Chemotherapy Toxicity in Isolated Rat Hearts.
A. Ramond, E. Sartorius, M. Mousseau, C. Ribuot, and M. Joyeux-Faure (2008)
Experimental Biology and Medicine 233, 76-83
   Abstract »    Full Text »    PDF »
Pharmacological Inhibition of CB1 Cannabinoid Receptor Protects Against Doxorubicin-Induced Cardiotoxicity.
P. Mukhopadhyay, S. Batkai, M. Rajesh, N. Czifra, J. Harvey-White, G. Hasko, Z. Zsengeller, N. P. Gerard, L. Liaudet, G. Kunos, et al. (2007)
J. Am. Coll. Cardiol. 50, 528-536
   Abstract »    Full Text »    PDF »
Over-expression of heat shock protein 27 attenuates doxorubicin-induced cardiac dysfunction in mice.
L. Liu, X. Zhang, B. Qian, X. Min, X. Gao, C. Li, Y. Cheng, and J. Huang (2007)
Eur J Heart Fail 9, 762-769
   Abstract »    Full Text »    PDF »
Disruption of Nitric Oxide Synthase 3 Protects Against the Cardiac Injury, Dysfunction, and Mortality Induced by Doxorubicin.
T. G. Neilan, S. L. Blake, F. Ichinose, M. J. Raher, E. S. Buys, D. S. Jassal, E. Furutani, T. M. Perez-Sanz, A. Graveline, S. P. Janssens, et al. (2007)
Circulation 116, 506-514
   Abstract »    Full Text »    PDF »
Zinc Inhibits Doxorubicin-Activated Calcineurin Signal Transduction Pathway in H9c2 Embryonic Rat Cardiac Cells.
K. E. Merten, Y. Jiang, and Y. J. Kang (2007)
Experimental Biology and Medicine 232, 682-689
   Abstract »    Full Text »    PDF »
Calcineurin Activation Is Not Necessary for Doxorubicin-Induced Hypertrophy in H9c2 Embryonic Rat Cardiac Cells: Involvement of the Phosphoinositide 3-Kinase-Akt Pathway.
K. E. Merten, Y. Jiang, W. Feng, and Y. J. Kang (2006)
J. Pharmacol. Exp. Ther. 319, 934-940
   Abstract »    Full Text »    PDF »
Increase in Mrp1 expression and 4-hydroxy-2-nonenal adduction in heart tissue of Adriamycin-treated C57BL/6 mice..
P. Jungsuwadee, M. P. Cole, R. Sultana, G. Joshi, J. Tangpong, D. A. Butterfield, D. K. St. Clair, and M. Vore (2006)
Mol. Cancer Ther. 5, 2851-2860
   Abstract »    Full Text »    PDF »
DNA damage is an early event in doxorubicin-induced cardiac myocyte death.
T. L'Ecuyer, S. Sanjeev, R. Thomas, R. Novak, L. Das, W. Campbell, and R. V. Heide (2006)
Am J Physiol Heart Circ Physiol 291, H1273-H1280
   Abstract »    Full Text »    PDF »
Transcriptional analysis of doxorubicin-induced cardiotoxicity.
X. Yi, R. Bekeredjian, N. J. DeFilippis, Z. Siddiquee, E. Fernandez, and R. V. Shohet (2006)
Am J Physiol Heart Circ Physiol 290, H1098-H1102
   Abstract »    Full Text »    PDF »
Usefulness of anti-oxidized LDL antibody determination for assessment of clinical control in patients with heart failure.
J. George, D. Wexler, A. Roth, T. Barak, D. Sheps, and G. Keren (2006)
Eur J Heart Fail 8, 58-62
   Abstract »    Full Text »    PDF »
Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart.
A. J. Chicco, C. M. Schneider, and R. Hayward (2005)
Am J Physiol Regulatory Integrative Comp Physiol 289, R424-R431
   Abstract »    Full Text »    PDF »
Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure.
F.-F. Liu, J. R. Stone, A. J. T. Schuldt, K. Okoshi, M. P. Okoshi, M. Nakayama, K. K. L. Ho, W. J. Manning, M. A. Marchionni, B. H. Lorell, et al. (2005)
Am J Physiol Heart Circ Physiol 289, H660-H666
   Abstract »    Full Text »    PDF »
Coenzyme Q10 for Prevention of Anthracycline-Induced Cardiotoxicity.
K. A. Conklin (2005)
Integr Cancer Ther 4, 110-130
   Abstract »    PDF »
Doxorubicin Inhibits DNMT1, Resulting in Conditional Apoptosis.
T. Yokochi and K. D. Robertson (2004)
Mol. Pharmacol. 66, 1415-1420
   Abstract »    Full Text »    PDF »
The Influence of Anthracycline Therapy on Cardiac Function During Anesthesia.
E. Huettemann, T. Junker, K. P. Chatzinikolaou, G. Petrat, S. G. Sakka, L. Vogt, and K. Reinhart (2004)
Anesth. Analg. 98, 941-947
   Abstract »    Full Text »    PDF »
Influence of Dosing Schedule on Toxicity and Antitumor Effects of a Combination of Adriamycin and Docetaxel in Mice.
H. To, M. Shin, M. Tabuchi, H. Sakaguchi, A. Takeuchi, N. Matsunaga, S. Higuchi, and S. Ohdo (2004)
Clin. Cancer Res. 10, 762-769
   Abstract »    Full Text »    PDF »
Nutritional Approaches to Late Toxicities of Adjuvant Chemotherapy in Breast Cancer Survivors.
E. Rock and A. DeMichele (2003)
J. Nutr. 133, 3785S-3793
   Abstract »    Full Text »    PDF »
Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin.
C. J. Miranda, H. Makui, R. J. Soares, M. Bilodeau, J. Mui, H. Vali, R. Bertrand, N. C. Andrews, and M. M. Santos (2003)
Blood 102, 2574-2580
   Abstract »    Full Text »    PDF »
Protective role of DLa-lipoic acid against adriamycin-induced cardiac lipid peroxidation.
A V Balachandar, K P Malarkodi, and P Varalakshmi (2003)
Human and Experimental Toxicology 22, 249-254
   Abstract »    PDF »
Potent Metalloporphyrin Peroxynitrite Decomposition Catalyst Protects Against the Development of Doxorubicin-Induced Cardiac Dysfunction.
P. Pacher, L. Liaudet, P. Bai, J. G. Mabley, P. M. Kaminski, L. Virag, A. Deb, E. Szabo, Z. Ungvari, M. S. Wolin, et al. (2003)
Circulation 107, 896-904
   Abstract »    Full Text »    PDF »
Transferrin Receptor-dependent Iron Uptake Is Responsible for Doxorubicin-mediated Apoptosis in Endothelial Cells. ROLE OF OXIDANT-INDUCED IRON SIGNALING IN APOPTOSIS.
S. Kotamraju, C. R. Chitambar, S. V. Kalivendi, J. Joseph, and B. Kalyanaraman (2002)
J. Biol. Chem. 277, 17179-17187
   Abstract »    Full Text »    PDF »
Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients.
B. V. Jensen, T. Skovsgaard, and S. L. Nielsen (2002)
Ann. Onc. 13, 699-709
   Abstract »    Full Text »    PDF »
Activation of Poly(ADP-Ribose) Polymerase Contributes to Development of Doxorubicin-Induced Heart Failure.
P. Pacher, L. Liaudet, P. Bai, L. Virag, J. G. Mabley, G. Hasko, and C. Szabo (2002)
J. Pharmacol. Exp. Ther. 300, 862-867
   Abstract »    Full Text »    PDF »
Antitumor Activity of ER-37328, a Novel Carbazole Topoisomerase II Inhibitor.
K. Nakamura, H. Sugumi, A. Yamaguchi, T. Uenaka, Y. Kotake, T. Okada, J. Kamata, J. Niijima, T. Nagasu, N. Koyanagi, et al. (2002)
Mol. Cancer Ther. 1, 169-175
   Abstract »    Full Text »    PDF »
Doxorubicin-induced Apoptosis Is Associated with Increased Transcription of Endothelial Nitric-oxide Synthase. EFFECT OF ANTIAPOPTOTIC ANTIOXIDANTS AND CALCIUM.
S. V. Kalivendi, S. Kotamraju, H. Zhao, J. Joseph, and B. Kalyanaraman (2001)
J. Biol. Chem. 276, 47266-47276
   Abstract »    Full Text »    PDF »
The Oxidative Stress Hypothesis of Congestive Heart Failure : Radical Thoughts.
S. Mak and G. E. Newton (2001)
Chest 120, 2035-2046
   Abstract »    Full Text »    PDF »
Effects of water-soluble antioxidant from spinach, NAO, on doxorubicin-induced heart injury.
E Breitbart, L Lomnitski, A Nyska, Z Malik, M Bergman, Y Sofer, J K Haseman, and S Grossman (2001)
Human and Experimental Toxicology 20, 337-345
   Abstract »    PDF »
Attenuation of Doxorubicin Chronic Toxicity in Metallothionein-overexpressing Transgenic Mouse Heart.
X. Sun, Z. Zhou, and Y. J. Kang (2001)
Cancer Res. 61, 3382-3387
   Abstract »    Full Text »
Reduced Cardiotoxicity and Preserved Antitumor Efficacy of Liposome-Encapsulated Doxorubicin and Cyclophosphamide Compared With Conventional Doxorubicin and Cyclophosphamide in a Randomized, Multicenter Trial of Metastatic Breast Cancer.
G. Batist, G. Ramakrishnan, C. S. Rao, A. Chandrasekharan, J. Gutheil, T. Guthrie, P. Shah, A. Khojasteh, M. K. Nair, K. Hoelzer, et al. (2001)
J. Clin. Oncol. 19, 1444-1454
   Abstract »    Full Text »    PDF »
Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats.
T. Li, I. Danelisen, A. Bello-Klein, and P. K. Singal (2000)
Cardiovasc Res 46, 523-530
   Abstract »    Full Text »    PDF »
Suppression by Metallothionein of Doxorubicin-induced Cardiomyocyte Apoptosis through Inhibition of p38 Mitogen-activated Protein Kinases.
Y. J. Kang, Z.-X. Zhou, G.-W. Wang, A. Buridi, and J. B. Klein (2000)
J. Biol. Chem. 275, 13690-13698
   Abstract »    Full Text »    PDF »
7-Monohydroxyethylrutoside Protects against Chronic Doxorubicin-induced Cardiotoxicity When Administered Only Once Per Week.
F. A. A. van Acker, S. A. B. E. van Acker, K. Kramer, G. R. M. M. Haenen, A. Bast, and W. J. F. van der Vijgh (2000)
Clin. Cancer Res. 6, 1337-1341
   Abstract »    Full Text »
Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy.
K. Kunisada, S. Negoro, E. Tone, M. Funamoto, T. Osugi, S. Yamada, M. Okabe, T. Kishimoto, and K. Yamauchi-Takihara (2000)
PNAS 97, 315-319
   Abstract »    Full Text »    PDF »
The Antioxidant Function of Metallothionein in the Heart.
Y. J. Kang (1999)
Experimental Biology and Medicine 222, 263-273
   Abstract »    Full Text »
MAPK Superfamily Plays an Important Role in Daunomycin-Induced Apoptosis of Cardiac Myocytes.
W. Zhu, Y. Zou, R. Aikawa, K. Harada, S. Kudoh, H. Uozumi, D. Hayashi, Y. Gu, T. Yamazaki, R. Nagai, et al. (1999)
Circulation 100, 2100-2107
   Abstract »    Full Text »    PDF »
L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation.
N. ANDRIEU-ABADIE, J.-P. JAFFRÉZOU, S. HATEM, G. LAURENT, T. LEVADE, and J.-J. MERCADIER (1999)
FASEB J 13, 1501-1510
   Abstract »    Full Text »
Nitric Oxide Synthases Catalyze the Activation of Redox Cycling and Bioreductive Anticancer Agents.
A. P. Garner, M. J. I. Paine, I. Rodriguez-Crespo, E. C. Chinje, P. O. De Montellano, I. J. Stratford, D. G. Tew, and C. R. Wolf (1999)
Cancer Res. 59, 1929-1934
   Abstract »    Full Text »    PDF »
Inhibition of Doxorubicin Toxicity in Cultured Neonatal Mouse Cardiomyocytes with Elevated Metallothionein Levels.
G.-W. Wang and Y. J. Kang (1999)
J. Pharmacol. Exp. Ther. 288, 938-944
   Abstract »    Full Text »
1,25-Dihydroxyvitamin D3 Enhances the Susceptibility of Breast Cancer Cells to Doxorubicin-induced Oxidative Damage.
A. Ravid, D. Rocker, A. Machlenkin, C. Rotem, A. Hochman, G. Kessler-Icekson, U. A. Liberman, and R. Koren (1999)
Cancer Res. 59, 862-867
   Abstract »    Full Text »    PDF »
A canine model of dilated cardiomyopathy induced by repetitive intracoronary doxorubicin administration.
Y. Toyoda, M. Okada, and M. A. Kashem (1998)
J. Thorac. Cardiovasc. Surg. 115, 1367-1374
   Abstract »    Full Text »    PDF »
Free radical involvement in doxorubicin-induced electrophysiological alterations in rat papillary muscle fibres.
P Venditti, M Balestrieri, T De Leo, and S Di Meo (1998)
Cardiovasc Res 38, 695-702
   Abstract »    Full Text »    PDF »
Oxidative Stress Increases A1 Adenosine Receptor Expression by Activating Nuclear Factor kappa B.
Z. Nie, Y. Mei, M. Ford, L. Rybak, A. Marcuzzi, H. Ren, G. L. Stiles, and V. Ramkumar (1998)
Mol. Pharmacol. 53, 663-669
   Abstract »    Full Text »
Xenobiotic-induced hepatotoxicity: mechanisms of liver injury and methods of monitoring hepatic function.
M. G. Sturgill and G. H. Lambert (1997)
Clin. Chem. 43, 1512-1526
   Abstract »    Full Text »    PDF »
Suppression of Doxorubicin Cardiotoxicity by Overexpression of Catalase in the Heart of Transgenic Mice.
Y. J. Kang, Y. Chen, and P. N. Epstein (1996)
J. Biol. Chem. 271, 12610-12616
   Abstract »    Full Text »    PDF »
Antioxidant Action of Vitamins A and E in Patients Submitted to Coronary Artery Bypass Surgery.
R. Federico Ferreira, J. Milei, S. Llesuy, B. Gonzalez Flecha, H. Hourquebie, L. Molteni, C. de Palma, A. Paganini, L. Scervino, and A. Boveris (1991)
Vascular and Endovascular Surgery 25, 191-195
   Abstract »    PDF »
Long-Term Complications of Antineoplastic Agents.
L. E. Davis (1991)
Journal of Pharmacy Practice 4, 131-150
   PDF »
The Role of Selenium Compounds in Cancer Therapy.
G. Batist, A.G. Katki, V.J. Ferrans, and C.E. Myers (1986)
International Journal of Toxicology 5, 87-93
   Abstract »    PDF »
Dissociation of antitumor potency from anthracycline cardiotoxicity in a doxorubicin analog.
B. Sikic, M. Ehsan, W. Harker, N. Friend, B. Brown, R. Newman, M. Hacker, and E. Acton (1985)
Science 228, 1544-1546
   Abstract »    PDF »
Oncology: An Annotated Bibliography of Recent Literature: References to Journal Articles and Other Papers.
(1982)
Ann Intern Med 97, 630-635
   Abstract »    PDF »
Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous Infusion.
S. S. LEGHA, R. S. BENJAMIN, B. MACKAY, M. EWER, S. WALLACE, M. VALDIVIESO, S. L. RASMUSSEN, G. R. BLUMENSCHEIN, and E. J. FREIREICH (1982)
Ann Intern Med 96, 133-139
   Abstract »    PDF »
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure.
D. D. VON HOFF, M. W. LAYARD, P. BASA, H. L. DAVIS Jr., A. L. VON HOFF, M. ROZENCWEIG, and F. M. MUGGIA (1979)
Ann Intern Med 91, 710-717
   Abstract »    PDF »
Multiple Thromboemboli.
J. S. ROLOFF, R. D. COLLINS, and J. N. LUKENS (1978)
Arch Pediatr Adolesc Med 132, 1042-1043
   Abstract »    PDF »
Adjuvant Therapy of Breast Cancer: Accomplishments and Future Course.
B. A. Chabner, M. Cohen, and M. Lippman (1978)
JAMA 239, 2373-2374
   Abstract »    PDF »
Doxorubicin-induced Apoptosis in Endothelial Cells and Cardiomyocytes Is Ameliorated by Nitrone Spin Traps and Ebselen. ROLE OF REACTIVE OXYGEN AND NITROGEN SPECIES.
S. Kotamraju, E. A. Konorev, J. Joseph, and B. Kalyanaraman (2000)
J. Biol. Chem. 275, 33585-33592
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)